Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
Introduction: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the newest class of oral antihyperglycemic medications approved for the treatment of type 2 diabetes mellitus (DM2). Although they are not approved for use in type 1 diabetes mellitus (DM1), SGLT2 inhibitors may help DM1 patients a...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-12-01
|
Series: | Journal of Primary Care & Community Health |
Online Access: | https://doi.org/10.1177/2150132719895188 |